| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.098 | 0.1 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |